Clinical Trial Update: Study of Muscle Abnormalities in Patients With Specific Genetic Mutations

View source ↗

Summary

An NHLBI-sponsored clinical trial evaluating muscle abnormalities in patients with specific genetic mutations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Oculopharyngeal Muscular Dystrophy

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiomyopathy, Hypertrophic, Muscular Dystrophy, Oculopharyngeal | Status: COMPLETED